LIGAND PHARMACEUTICALS INCORPORATED Stock Repurchase Program, Authorized Amount
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Stock Repurchase Program, Authorized Amount of $50.00 million as of 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2024-05-08
- 2024-03-31: Stock Repurchase Program, Authorized Amount $50.00M.
- 2023-09-30: Stock Repurchase Program, Authorized Amount $50.00M.
- 2023-06-30: Stock Repurchase Program, Authorized Amount $50.00M.
- 2023-04-30: Stock Repurchase Program, Authorized Amount $50.00M.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2024-03-31 | $50.00M 10-Q · filed 2024-05-08 |
| 2023-09-30 | $50.00M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $50.00M 10-Q · filed 2023-08-09 |
| 2023-04-30 | $50.00M 10-K · filed 2024-02-29 |
| 2019-09-30 | $500.00M 10-K · filed 2023-02-28 |
| 2019-09-11 | $500.00M 10-Q · filed 2022-11-08 |
| 2019-01-23 | $350.00M 10-K · filed 2022-02-28 |
| 2018-09-30 | $200.00M 10-K · filed 2021-02-24 |
| 2016-09-30 | $200.00M 10-K · filed 2020-02-27 |
| 2015-09-30 | $200.00M 10-K · filed 2019-02-28 |
| 2014-08-31 | $200.00M 10-K · filed 2016-11-14 |
| 2014-05-08 | $5.00M 10-Q · filed 2014-08-05 |